Figure 5From: Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial Cost-effectiveness acceptability curve: RPT versus TAU; societal perspective; effectiveness measured on the EQ VAS scale. Back to article page